Skip to main content
. 2019 Apr 22;13(4):e0007345. doi: 10.1371/journal.pntd.0007345

Fig 4. rAceySKPI3/Alhydrogel vaccine trial.

Fig 4

(A) rAceySKPI3 serum IgG titers in Alhydrogel controls and rAceySKPI3/Alhydrogel vaccinates. Dotted lines indicate the inverse of serum dilutions tested. (B) Comparison of mean hookworm burden between rAceySKPI3/Alhydrogel and Alhydrogel control vaccinates. (C) Comparison of mean FEC between rAceySKPI3/Alhydrogel and Alhydrogel control vaccinates. (D) Comparison of mean change in weight after hookworm infection between rAceySKPI3/Alhydrogel and Alhydrogel control vaccinates. (E) Comparison of mean change in hemoglobin concentration after hookworm infection between rAceySKPI3/Alhydrogel and Alhydrogel control vaccinates. (B, C) For rAceySKPI3/Alhydrogel, n = 7 as 1 vaccinate died on day 21 PI (i.e., one day after obtaining Δweight (D) and Δhemoglobin (E); hookworm burden and FEC were determined on day 23 PI).